vs
Side-by-side financial comparison of Monolithic Power Systems (MPWR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $751.2M, roughly 2.0× Monolithic Power Systems). Monolithic Power Systems runs the higher net margin — 22.9% vs 4.4%, a 18.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 20.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $63.9M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 28.1%).
Monolithic Power Systems, Inc. is an American, publicly traded company headquartered in Kirkland, Washington. It operates in more than 15 locations worldwide.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
MPWR vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $751.2M | $1.5B |
| Net Profit | $171.7M | $66.5M |
| Gross Margin | 55.2% | 90.5% |
| Operating Margin | 26.6% | 12.4% |
| Net Margin | 22.9% | 4.4% |
| Revenue YoY | 20.8% | 32.8% |
| Net Profit YoY | -86.3% | 143.8% |
| EPS (diluted) | $3.50 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $751.2M | $1.5B | ||
| Q3 25 | $737.2M | $1.4B | ||
| Q2 25 | $664.6M | $1.3B | ||
| Q1 25 | $637.6M | $1.1B | ||
| Q4 24 | $621.7M | $1.1B | ||
| Q3 24 | $620.1M | $1.0B | ||
| Q2 24 | $507.4M | $929.2M | ||
| Q1 24 | $457.9M | $751.7M |
| Q4 25 | $171.7M | $66.5M | ||
| Q3 25 | $179.8M | $124.8M | ||
| Q2 25 | $135.0M | $94.3M | ||
| Q1 25 | $135.1M | $1.3M | ||
| Q4 24 | $1.3B | $-151.9M | ||
| Q3 24 | $144.4M | $-121.3M | ||
| Q2 24 | $100.4M | $-120.4M | ||
| Q1 24 | $92.5M | $-251.2M |
| Q4 25 | 55.2% | 90.5% | ||
| Q3 25 | 55.1% | 86.1% | ||
| Q2 25 | 55.1% | 87.5% | ||
| Q1 25 | 55.4% | 85.2% | ||
| Q4 24 | 55.4% | 85.8% | ||
| Q3 24 | 55.4% | 83.0% | ||
| Q2 24 | 55.3% | 85.1% | ||
| Q1 24 | 55.1% | 83.4% |
| Q4 25 | 26.6% | 12.4% | ||
| Q3 25 | 26.5% | 11.5% | ||
| Q2 25 | 24.8% | 6.7% | ||
| Q1 25 | 26.5% | 1.0% | ||
| Q4 24 | 26.3% | -7.0% | ||
| Q3 24 | 26.5% | -12.0% | ||
| Q2 24 | 23.0% | -11.5% | ||
| Q1 24 | 20.9% | -34.8% |
| Q4 25 | 22.9% | 4.4% | ||
| Q3 25 | 24.4% | 8.8% | ||
| Q2 25 | 20.3% | 7.2% | ||
| Q1 25 | 21.2% | 0.1% | ||
| Q4 24 | 201.8% | -13.5% | ||
| Q3 24 | 23.3% | -12.1% | ||
| Q2 24 | 19.8% | -13.0% | ||
| Q1 24 | 20.2% | -33.4% |
| Q4 25 | $3.50 | $0.05 | ||
| Q3 25 | $3.74 | $0.08 | ||
| Q2 25 | $2.81 | $0.06 | ||
| Q1 25 | $2.81 | $0.00 | ||
| Q4 24 | $25.71 | $-0.10 | ||
| Q3 24 | $2.95 | $-0.09 | ||
| Q2 24 | $2.05 | $-0.09 | ||
| Q1 24 | $1.89 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $3.5B | $4.4B |
| Total Assets | $4.2B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $4.5B | ||
| Q3 25 | $1.3B | $4.0B | ||
| Q2 25 | $1.1B | $2.8B | ||
| Q1 25 | $1.0B | $2.5B | ||
| Q4 24 | $862.9M | $2.6B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.3B | $2.8B |
| Q4 25 | — | $836.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.5B | $4.4B | ||
| Q3 25 | $3.4B | $4.1B | ||
| Q2 25 | $3.2B | $3.8B | ||
| Q1 25 | $3.1B | $3.5B | ||
| Q4 24 | $3.0B | $3.3B | ||
| Q3 24 | $2.4B | $3.4B | ||
| Q2 24 | $2.2B | $3.4B | ||
| Q1 24 | $2.1B | $3.4B |
| Q4 25 | $4.2B | $8.2B | ||
| Q3 25 | $4.1B | $7.6B | ||
| Q2 25 | $3.9B | $6.3B | ||
| Q1 25 | $3.7B | $5.8B | ||
| Q4 24 | $3.5B | $5.9B | ||
| Q3 24 | $2.9B | $5.8B | ||
| Q2 24 | $2.6B | $5.7B | ||
| Q1 24 | $2.6B | $5.7B |
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $104.9M | $417.3M |
| Free Cash FlowOCF − Capex | $63.9M | $379.8M |
| FCF MarginFCF / Revenue | 8.5% | 25.4% |
| Capex IntensityCapex / Revenue | 5.5% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.61× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $666.2M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.9M | $417.3M | ||
| Q3 25 | $239.3M | $402.6M | ||
| Q2 25 | $237.6M | $263.6M | ||
| Q1 25 | $256.4M | $44.1M | ||
| Q4 24 | $167.7M | $75.2M | ||
| Q3 24 | $231.7M | $188.4M | ||
| Q2 24 | $141.0M | $-95.6M | ||
| Q1 24 | $248.1M | $-308.6M |
| Q4 25 | $63.9M | $379.8M | ||
| Q3 25 | $196.8M | $354.5M | ||
| Q2 25 | $189.5M | $219.8M | ||
| Q1 25 | $216.0M | $-12.3M | ||
| Q4 24 | $102.9M | $-17.3M | ||
| Q3 24 | $197.9M | $54.7M | ||
| Q2 24 | $109.5M | $-205.5M | ||
| Q1 24 | $232.1M | $-465.1M |
| Q4 25 | 8.5% | 25.4% | ||
| Q3 25 | 26.7% | 25.1% | ||
| Q2 25 | 28.5% | 16.7% | ||
| Q1 25 | 33.9% | -1.1% | ||
| Q4 24 | 16.5% | -1.5% | ||
| Q3 24 | 31.9% | 5.5% | ||
| Q2 24 | 21.6% | -22.1% | ||
| Q1 24 | 50.7% | -61.9% |
| Q4 25 | 5.5% | 2.5% | ||
| Q3 25 | 5.8% | 3.4% | ||
| Q2 25 | 7.2% | 3.3% | ||
| Q1 25 | 6.3% | 5.0% | ||
| Q4 24 | 10.4% | 8.2% | ||
| Q3 24 | 5.5% | 13.3% | ||
| Q2 24 | 6.2% | 11.8% | ||
| Q1 24 | 3.5% | 20.8% |
| Q4 25 | 0.61× | 6.28× | ||
| Q3 25 | 1.33× | 3.22× | ||
| Q2 25 | 1.76× | 2.79× | ||
| Q1 25 | 1.90× | 34.71× | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 2.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
